ISU Abxis Co., Ltd.

22 Daewangpangyo-ro 712beon-gil, Bundang-gu, Seongnam, Gyeonggi, South Korea

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

44.4%

Phase 3

33.3%

Phase 2

11.1%

Trial Status Distribution

Completed

55.6%

Recruiting

11.1%

Unknown

22.2%

Withdrawn

11.1%

Clinical Trials

Trials sponsored by this organization (9)

Evaluate the Safety and Efficacy of Fabagal® (Agalsidase Beta) in Patients With Fabry Disease

Phase 3

Recruiting

interventional

Apr 202324 participants

A Phase I Study to Compare Abcertin and EU-sourced Cerezyme® in Healthy Volunteers

Phase 1

Completed

interventional

Jan 202042 participants

Study of ISU104, Targeting ERBB3 in Patients With Advanced Solid Tumors

Phase 1

Unknown

interventional

Apr 201833 participants

Dose-escalation Study to Investigate the Safety, PK, and PD of ISU304/CB2679d in Hemophilia B Patients

Phase 1

Completed

interventional

Jun 201711 participants

Exploratory P2 Trial to Evaluate Efficacy and Safety of Clotinab® (Abciximab) in Acute MI Patients

Phase 2

Unknown

interventional

May 2013146 participants

Phase III Study of ISU302 in Patients With Type 1 Gaucher Disease

Phase 3

Completed

interventional

Sep 20118 participants

A Switch-Over Study of the Safety and Efficacy of ISU302 in Patients With Type 1 Gaucher Disease

Completed

observational

May 20115 participants

The Safety and Efficacy Study of ISU302 in Patient With Type I Gaucher Disease

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations